I agree that this site is using cookies. You can find further informations here.
X
Oluwole, Olalekan O.
675  results:
Search for persons X
?
1

Cost-effectiveness of treating relapsed or refractory 3L+ f..:

Oluwole, Olalekan O. ; Ray, Markqayne D. ; Zur, Richard M....
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Defining the Optimal Post-CART Monitoring Period in Recipie..:

Wesson, William ; Riedell, Peter A. ; Porter, David L....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S206-S207 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Three-year follow-up analysis of axicabtagene ciloleucel in..:

Neelapu, Sattva S. ; Chavez, Julio C. ; Sehgal, Alison R....
Blood.  143 (2024)  6 - p. 496-506 , 2024
Link: https://doi.org/10.1182/..
 
?
4

Network meta-analysis of CAR T-Cell therapy for the treatme..:

Oluwole, Olalekan O. ; Neelapu, Sattva S. ; Ray, Markqayne D....
Expert Review of Anticancer Therapy.  24 (2024)  6 - p. 457-465 , 2024
Link: https://doi.org/10.1080/..
 
?
5

ACT To Sustain: Adoptive Cell Therapy To Sustain Access to ..:

Gardner, Rebecca A. ; White, Claire ; Elsallab, Magdi...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Building the Future of CAR-T Therapy: Empowering Clinicians..:

DeLuca, Carmine ; Massey, Jessica ; Beyer, Michael...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S154-S155 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Cost-effectiveness of axicabtagene ciloleucel versus tisage..:

Oluwole, Olalekan O. ; Ray, Markqayne D. ; Davies, Neil...
Journal of Medical Economics.  27 (2024)  1 - p. 230-239 , 2024
Link: https://doi.org/10.1080/..
 
?
8

Outcomes of subsequent antilymphoma therapies after second-..:

Ghobadi, Armin ; Munoz, Javier ; Westin, Jason R....
Blood Advances.  8 (2024)  11 - p. 2982-2990 , 2024
Link: https://doi.org/10.1182/..
 
?
9

Chimeric Antigen Receptor T-Cell Therapy in the Outpatient ..:

Oluwole, Olalekan O. ; Dholaria, Bhagirathbhai ; Knight, Tristan E....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. 131-142 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Long-term outcomes of patients with large B-cell lymphoma t..:

Oluwole, Olalekan O. ; Forcade, Edouard ; Muñoz, Javier...
Bone Marrow Transplantation.  59 (2024)  3 - p. 366-372 , 2024
Link: https://doi.org/10.1038/..
 
?
11

Matching-Adjusted Indirect Comparisons of Axicabtagene Cilo..:

Ray, Markqayne D. ; Kanters, Steve ; Beygi, Sara...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
12

Axicabtagene ciloleucel vs standard of care in second-line ..:

Locke, Frederick L. ; Oluwole, Olalekan O. ; Kuruvilla, John...
Blood.  143 (2024)  24 - p. 2464-2473 , 2024
Link: https://doi.org/10.1182/..
 
?
13

Clinical Practice Recommendations for Hematopoietic Cell Tr..:

Iqbal, Madiha ; Kumar, Ambuj ; Dreger, Peter...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
14

Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where..:

Anderson Jr, Larry D. ; Dhakal, Binod ; Jain, Tania...
Transplantation and Cellular Therapy.  30 (2024)  1 - p. 17-37 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Interim Analysis of Prospective Clinical Trial of Outpatien..:

Dholaria, Dr. Bhagirathbhai ; Bhaskar, Shakthi T ; Patel, Vivek G....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S220-S221 , 2024
Link: https://doi.org/10.1016/..
 
1-15